D. Western Therapeutics Institute, Inc. (TYO:4576)
Japan · Delayed Price · Currency is JPY 67.00
-2.00 (-2.90%)
Sep 16, 2026, 3:30 PM JST
TYO:4576 Market Cap
TYO:4576 has a market cap or net worth of 3.86 billion as of September 15, 2026. Its market cap has decreased by -18.95% in one year.
Market Cap
3.86B
Enterprise Value
2.86B
Revenue
247.00M
Ranking
n/a
PE Ratio
n/a
Stock Price
67.00
ChartMarket Cap Chart
Since October 23, 2009, TYO:4576's market cap has decreased from 6.60B to 3.86B, a decrease of -41.59%. That is a compound annual growth rate of -3.13%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 16, 2026 | 3.86B | -25.97% |
| Dec 30, 2025 | 5.21B | -36.69% |
| Dec 30, 2024 | 8.23B | 81.59% |
| Dec 29, 2023 | 4.53B | -43.36% |
| Dec 30, 2022 | 8.00B | 26.13% |
| Dec 30, 2021 | 6.34B | -24.98% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Cyfuse Biomedical K.K. | 6.68B |
| CellSource | 6.43B |
| Noile-Immune Biotech | 6.03B |
| PRISM BioLab Co.,LTD | 5.95B |
| TMS Co., Ltd. | 5.71B |
| Soiken Holdings | 5.57B |
| Chordia Therapeutics | 5.33B |
| Ribomic | 4.47B |